HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Competition Drives Personal-Care Ad Spend In Early 2013 – Kantar Media

This article was originally published in The Rose Sheet

Executive Summary

After creeping up 5% from 2011 to 2012, ad spending in 2013 is on pace to jump dramatically among the biggest players in the personal-care industry.

You may also be interested in...



P&G Beauty’s Sluggish 2012: The Cost Of Cutting Back?

Kline’s Nancy Mills offers perspective on P&G performance in 2012 when the company saw its market share slip in certain personal-care categories. In her blog post, Mills attributes the erosion in part to the firm’s ongoing $10 billion cost-cutting initiative, which slowed new product introductions and left some brands under-supported in a highly competitive landscape, she says.

P&G Targets $10 Billion In Cost Savings In Four Years

P&G will $10 billion in costs by the end of fiscal 2016, firm says at Analyst Group of New York Conference Feb. 23. Firm aims to derive $3 billion of that from reduced overhead, with plans to cut 5,700 jobs by the end of next fiscal year.

Women’s Voices For The Earth Will Keep After CIR, Salon Worker Safety In 2024

Women’s Voices for the Earth continues to call attention to cosmetic ingredients’ potential health impacts on users including salon workers, while pushing the Cosmetic Ingredient Review to consider a wider variety of safety information in its assessment work.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS018627

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel